AR082141A1 - Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel - Google Patents
Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la pielInfo
- Publication number
- AR082141A1 AR082141A1 ARP110102461A ARP110102461A AR082141A1 AR 082141 A1 AR082141 A1 AR 082141A1 AR P110102461 A ARP110102461 A AR P110102461A AR P110102461 A ARP110102461 A AR P110102461A AR 082141 A1 AR082141 A1 AR 082141A1
- Authority
- AR
- Argentina
- Prior art keywords
- radical
- treatment
- xantenodiona
- pigmentation
- derivatives
- Prior art date
Links
- 230000019612 pigmentation Effects 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
- -1 C1-6 alkyl radical Chemical class 0.000 abstract 5
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 101100134922 Gallus gallus COR5 gene Proteins 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/08—Preparations for bleaching the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Compuesto de fórmula (1) genérica, en donde R1 y R2 representan: OH, un átomo de hidrógeno, un radical alquilo C1-6, alcoxi C1-6, halógeno, u OCOR3; R3 representa un radical alquilo C1-24, alquenilo C12-24 que comprende por lo menos una insaturación; R4 representa: COR5, un glúcido sustituido o no por uno o más radical(es) acetilo; R5 representa: un radical alquilo C10-24, o un radical alquenilo C12-24 que comprende por lo menos una insaturación entre 1 a 4; R6 y R7 representan simultáneamente un átomo de hidrógeno o un radical metilo, o cuando R6 representa un átomo de hidrógeno, R7 representa un radical alquilo C1-6 o un fenilo sustituido o no por uno o más radical(es) alcoxi C1-3 o uno o más halógeno(s); o R6 y R7 están unidos juntos y forman un cicloalquilo C3-6, y sales aceptables desde el punto de vista farmacéutico o cosmético. Se proveen además, método para su preparación, composiciones farmacéuticas que lo comprenden y su uso en el tratamiento del envejecimiento y/o la inflamación de la piel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1055595A FR2962436B1 (fr) | 2010-07-09 | 2010-07-09 | Derives de xanthedediones pour le traitement des troubles de la pigmentation et du vieillissement cutane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082141A1 true AR082141A1 (es) | 2012-11-14 |
Family
ID=43759812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110102461A AR082141A1 (es) | 2010-07-09 | 2011-07-08 | Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8906416B2 (es) |
| EP (1) | EP2590959A1 (es) |
| JP (1) | JP5829272B2 (es) |
| KR (1) | KR20130043181A (es) |
| CN (1) | CN102985415B (es) |
| AR (1) | AR082141A1 (es) |
| AU (1) | AU2011275686B2 (es) |
| BR (1) | BR112013000431A2 (es) |
| CA (1) | CA2804334A1 (es) |
| FR (1) | FR2962436B1 (es) |
| HK (1) | HK1178521A1 (es) |
| IL (1) | IL224123A (es) |
| MA (1) | MA34390B1 (es) |
| MX (1) | MX2013000077A (es) |
| NZ (1) | NZ605750A (es) |
| PH (1) | PH12013500026A1 (es) |
| RU (1) | RU2598374C2 (es) |
| SG (1) | SG186941A1 (es) |
| TW (1) | TWI538693B (es) |
| WO (1) | WO2012004390A1 (es) |
| ZA (1) | ZA201300413B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201444827A (zh) * | 2013-03-12 | 2014-12-01 | Daiichi Sankyo Co Ltd | 苯基□衍生物 |
| US12134623B1 (en) | 2023-10-17 | 2024-11-05 | King Faisal University | 2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU895985A1 (ru) * | 1980-03-27 | 1982-01-07 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | 9-Ароил-3,3,6,6-тетраметил-1,2,3,4,5,6,7,8-октагидроксантен-1,8-дионы в качестве промежуточных продуктов дл синтеза соединений,обладающих антиоксидантной активностью |
| JP3498857B2 (ja) * | 1994-01-28 | 2004-02-23 | 株式会社ノエビア | 皮膚外用剤 |
| GB9707695D0 (en) * | 1996-08-07 | 1997-06-04 | Hoffmann La Roche | Tricyclic dione derivatives |
| US7390668B2 (en) * | 1996-10-30 | 2008-06-24 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for photodynamic treatment of disease |
| FR2756183B1 (fr) * | 1996-11-25 | 1999-08-27 | Fabre Pierre Dermo Cosmetique | Association d'huile et de peptides d'argan utile pour le traitement des troubles lies au vieillissement cutane |
| ES2310521T3 (es) * | 1999-08-13 | 2009-01-16 | Provectus Pharmatech, Inc. | Medicamentos topicos mejorados y metodos que permiten el tratamiento de enfermedades de manera fotodinamica. |
| EP1213025A1 (de) | 2000-12-06 | 2002-06-12 | Laboratoires Serobiologiques(Societe Anonyme) | Kosmetische und/oder dermopharmazeutische Zubereitungen enthaltend Extrakte aus den Blättern der Pflanze Argania spinosa |
| GB0215534D0 (en) * | 2002-07-04 | 2002-08-14 | Ecole Polytech | Selective photochemotherapy using oligonucleotide targeting agents |
| US20060105069A1 (en) * | 2004-11-16 | 2006-05-18 | Alex Moffett | Pharmaceutical and therapeutic compositions derived from Garcinia mangostana L plant |
-
2010
- 2010-07-09 FR FR1055595A patent/FR2962436B1/fr not_active Expired - Fee Related
-
2011
- 2011-07-08 PH PH1/2013/500026A patent/PH12013500026A1/en unknown
- 2011-07-08 EP EP11730320.6A patent/EP2590959A1/en not_active Withdrawn
- 2011-07-08 JP JP2013517403A patent/JP5829272B2/ja not_active Expired - Fee Related
- 2011-07-08 AU AU2011275686A patent/AU2011275686B2/en not_active Ceased
- 2011-07-08 KR KR1020137003123A patent/KR20130043181A/ko not_active Application Discontinuation
- 2011-07-08 MX MX2013000077A patent/MX2013000077A/es active IP Right Grant
- 2011-07-08 SG SG2013000872A patent/SG186941A1/en unknown
- 2011-07-08 NZ NZ605750A patent/NZ605750A/en not_active IP Right Cessation
- 2011-07-08 CA CA2804334A patent/CA2804334A1/en not_active Abandoned
- 2011-07-08 BR BR112013000431A patent/BR112013000431A2/pt not_active IP Right Cessation
- 2011-07-08 AR ARP110102461A patent/AR082141A1/es unknown
- 2011-07-08 CN CN201180034125.0A patent/CN102985415B/zh not_active Expired - Fee Related
- 2011-07-08 US US13/808,456 patent/US8906416B2/en not_active Expired - Fee Related
- 2011-07-08 TW TW100124230A patent/TWI538693B/zh not_active IP Right Cessation
- 2011-07-08 MA MA35578A patent/MA34390B1/fr unknown
- 2011-07-08 RU RU2013103030/04A patent/RU2598374C2/ru not_active IP Right Cessation
- 2011-07-08 WO PCT/EP2011/061637 patent/WO2012004390A1/en active Application Filing
-
2013
- 2013-01-06 IL IL224123A patent/IL224123A/en active IP Right Grant
- 2013-01-16 ZA ZA2013/00413A patent/ZA201300413B/en unknown
- 2013-05-06 HK HK13105388.4A patent/HK1178521A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL224123A (en) | 2016-06-30 |
| US8906416B2 (en) | 2014-12-09 |
| RU2598374C2 (ru) | 2016-09-27 |
| FR2962436A1 (fr) | 2012-01-13 |
| MX2013000077A (es) | 2013-03-18 |
| ZA201300413B (en) | 2013-09-25 |
| CN102985415B (zh) | 2015-07-01 |
| AU2011275686A1 (en) | 2013-01-31 |
| MA34390B1 (fr) | 2013-07-03 |
| EP2590959A1 (en) | 2013-05-15 |
| RU2013103030A (ru) | 2014-08-20 |
| JP2013530203A (ja) | 2013-07-25 |
| CN102985415A (zh) | 2013-03-20 |
| TWI538693B (zh) | 2016-06-21 |
| PH12013500026A1 (en) | 2016-11-16 |
| FR2962436B1 (fr) | 2012-12-14 |
| SG186941A1 (en) | 2013-02-28 |
| TW201206488A (en) | 2012-02-16 |
| BR112013000431A2 (pt) | 2016-05-17 |
| AU2011275686B2 (en) | 2014-11-27 |
| KR20130043181A (ko) | 2013-04-29 |
| WO2012004390A1 (en) | 2012-01-12 |
| HK1178521A1 (en) | 2013-09-13 |
| US20130108568A1 (en) | 2013-05-02 |
| NZ605750A (en) | 2015-12-24 |
| CA2804334A1 (en) | 2012-01-12 |
| JP5829272B2 (ja) | 2015-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR077413A1 (es) | Derivados piridin-4-ilo | |
| AR081337A1 (es) | Derivados de 1,4-benzotiazepinas, composiciones farmaceuticas que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de trastornos metabolicos | |
| SV2009003376A (es) | Derivados de aril isoxazolinas insecticidas | |
| SV2008003088A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen | |
| DOP2012000150A (es) | Triazolopiridinas | |
| CU20110145A7 (es) | Derivados de sulfonamida | |
| DOP2014000133A (es) | Triazolopiridinas sustituidas | |
| ECSP13013011A (es) | Triazolopiridinas | |
| CO6620055A2 (es) | Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos | |
| SV2011003802A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| CR20140134A (es) | Composiciones farmacéuticas | |
| UY33452A (es) | Triazolopiridinas sustituidas | |
| AR074341A1 (es) | Derivados heterociclicos de isoindol, inhibidores de proteinasas bace, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento y/o prevencion de patologias relacionadas a deficiencias cognitivas, tales como alzheimer. | |
| AR076181A1 (es) | Compuestos derivados de mentol y uso de los mismos como agentes activos orales y sistemicos. metodo. composicion. | |
| EA201171339A1 (ru) | Способ снижения внутриглазного давления у людей | |
| AR074453A1 (es) | Compuestos 4-(azacicloalquil ) benceno-1,3-diol, como inhibidores de la tirosinasa y su uso en medicina humana y tambien en cosmetica | |
| BR112015004523A2 (pt) | compostos de tetraciclina | |
| GT201300322A (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
| AR081966A1 (es) | Derivados aminoester de alcaloides y composicion medicinal de los mismos | |
| UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
| AR082141A1 (es) | Derivados xantenodiona para el tratamiento de trastornos de pigmentacion y de envejecimiento de la piel | |
| AR084883A1 (es) | Derivados de 2-metoxi-piridin-4-ilo | |
| AR077429A1 (es) | Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos | |
| ECSP099328A (es) | Análogos de pirazol | |
| AR083991A1 (es) | Derivados glicinicos de azabiciclo[2.2.2]octano, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades respiratorias broncoobstructivas o inflamatorias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |